Main container

Sensibilità individuale dei pazienti in Terapia Anticoagulante Orale

Title
Sensibilità individuale dei pazienti in Terapia Anticoagulante Orale
Code
TAO-SAM
Type
Osservazionale
Start Year
2023
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
26/04/2023 14:50